|
List of Resources about
hyaluronic acid:
1. Marshall KW. Viscosupplementation for
osteoarthritis: current status, unresolved issues and future
directions. J Rheumatol 1998;25:2056-8.
2. George E. Intra-articular hyaluronan treatment for osteoarthritis.
Ann Rheum Dis 1998;57:637-40.
3. Wobig M, Bach G, Beks P, Dickhut A, Runzheimer J, Schwieger G, et
al. The role of elastoviscosity in the efficacy of
viscosupplementation for osteoarthritis of the knee: a comparison of
hylan G-F 20 and a lower-molecular-weight hyaluronan. Clin Ther
1999;21:1549-62.
4. Cohen MD. Hyaluronic acid treatment (viscosupplementation) for OA
of the knee. Bull Rheum Dis 1998;47:4-7.
5. Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the
treatment of osteoarthritis. J Rheumatol 1993;20(suppl 39):3-9.
6. Weiss C, Balazs EA, St. Onge R, Denlinger JL. Clinical studies of
the intraarticular injection of HealonR (sodium hyaluronate) in the
treatment of osteoarthritis of human knees. Osteoarthritis
symposium. Palm Aire, Fla., October 20-22, 1980. Semin Arthritis
Rheum. 1981;11(suppl 1):143-4.
7. Peyron JG. Intraarticular hyaluronan injections in the treatment of
osteoarthritis: state-of-the-art review. J Rheumatol
1993;39(suppl):10-5.
8. Henderson EB, Smith EC, Pegley F, Blake DR. Intra-articular
injections of 750 kD hyaluronan in the treatment of osteoarthritis:
a randomised single centre double-blind placebo-controlled trial of
91 patients demonstrating lack of efficacy. Ann Rheum Dis
1994;53:529-34.
9. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson
K, et al. Intra-articular hyaluronan injections in the treatment of
osteoarthritis of the knee: a randomised, double blind, placebo
controlled multicentre trial. Hyaluronan Mulicentre Trial Group. Ann
Rheum Dis 1996;55:424-31.
10. Dougados M, Nguyen M, Listrat V, Amor B. High molecular weight
sodium hyaluronate (hyalectin) in osteoarthritis of the knee: a 1
year placebo-controlled trial. Osteoarthritis Cart 1993;1:97-103.
11. Marshall KW. Viscosupplementation for osteoarthritis: current
status, unresolved issues and future directions. J Rheumatol
1998;25:2056-8.
12. Listrat V, Ayral X, Paternello F, Bonvarlet JP, Simonnet J, Amor
B, et al. Arthroscopic evaluation of potential structure modifying
activity of hyaluronan (Hyalgan) in osteoarthritis of the knee.
Osteoarthritis Cart 1997;5:153-60.
13. Altman RD, Moskowitz R. Intraarticular sodium hyaluronate
(Hyalgan) in the treatment of patients with osteoarthritis of the
knee: a randomized clinical trial. J Rheumatol 1998;25:2203-12
[Published erratum appears in J Rheumatol 1999;26:1216].
14. Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with
hylan G-F 20: a 26-week controlled trial of efficacy and safety in
the osteoarthritic knee. Clin Ther 1998;20:410-23.
15. Adams ME, Atkinson MH, Lussier AJ, Schulz JI, Siminovitch KA, Wade
JP, et al. The role of viscosupplementation with hylan G-F 20
(Synvisc) in the treatment of osteoarthritis of the knee: a Canadian
multicenter trial comparing hylan G-F 20 alone, hylan G-F 20 with
non-steroidal anti-inflammatory drugs (NSAIDs) and NSAIDs alone.
Osteoarthritis Cart 1995;3:213-25.
16. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ,
De Medicis R. Viscosupplementation with hylan for the treatment of
osteoarthritis: findings from clinical practice in Canada. J
Rheumatol 1996;23:1579-85.
17. Disla E, Infante R, Fahmy A, Karten I, Cuppari GG. Recurrent acute
calcium pyrophosphate dihydrate arthritis following intraarticular
hyaluronate injection. Arthritis Rheum 1999;42:1302-3.
18. Maheu E. Hyaluronan in knee osteoarthritis: a review of the
clinical trials with hyalgan. Eur J Rheumatol Inflamm 1995;15:17-24. |
